- Current report filing (8-K)
March 19 2009 - 12:16PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of
Report (Date of earliest event reported): September 27, 2007
Wellstar
International, Inc.
(Exact
name of registrant as specified in charter)
Nevada
|
333-130295
|
20-1834908
|
(State or
Other Jurisdiction of Incorporation or
Organization)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
6911
Pilliod Road
Holland,
Ohio 43528
(Address
of principal executive offices) (Zip Code)
Registrant's
telephone number, including area code: (419) 865-0069
Copies
to:
Darrin M.
Ocasio, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32
nd
Floor
New York,
New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
1.01 Entry Into A Material Definitive Agreement
On
September 27, 2007, Wellstar International, Inc.’s (the “Company”) wholly-owned
subsidiary, Trillennium Medical Imaging, Inc. (“Trillennium”), terminated its
Limited Technology License Agreement dated June 29, 2007 (the “Agreement”) with
Maclath Ltda. (“Licensee”), a Costa Rican corporation. In accordance
with Section 13.2 of the Agreement, on September 27, 2007, Trillenium served a
notice of default on Licensee terminating the Agreement. A copy of
the Agreement and a Copy of the Notice of Default are annexed as Exhibits
hereto.
Item 9.01 Financial Statements and
Exhibits
(c)
Exhibits.
Exhibit
Number
|
|
Description
|
10.1
|
|
Limited
Technology License Agreement dated July 9th, 2007, by and between
Trillennium Medical Imaging, Inc. and Maclath Ltda.
|
|
|
|
10.2
|
|
Notice
of Default dated September 27,2007 sent by Trillennium Medical Imaging,
Inc. to Maclath
Ltda.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
WELLSTAR
INTERNATIONAL, INC.
|
|
|
|
|
|
Date:
March 19, 2009
|
By:
|
/s/ John
Antonio
|
|
|
|
Name:
John Antonio
|
|
|
|
President
and Chief Executive Officer,
|
|
|
|
|
|
Wellstar (CE) (USOTC:WLSI)
Historical Stock Chart
From Oct 2024 to Oct 2024
Wellstar (CE) (USOTC:WLSI)
Historical Stock Chart
From Oct 2023 to Oct 2024